Hopital La Rabta Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00642330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

ibuprofen (motrin) (1 trial)

mifepristone (mifeprex) (1 trial)

misoprostol (cytotec) (1 trial)

Drugs in Phase 3 Trials (2)

rituximab (rituxan) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 4)

Ductus Arteriosus, Patent (Phase 4)

Purpura (Phase 3)

Purpura, Thrombocytopenic (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Thrombocytopenia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5